The Local Health Performance Incentive Program: Year 3. Office of Public Health Practice

Similar documents
Perinatal Hepatitis b Prevention

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Influenza : What is going on? How can Community Health Centers help their patients?

Gonorrhea, Chlamydia, and Syphilis in Alaska

2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing

Management of Gonorrhea in Adolescents and Adults in the United States

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

Best Practices in STD Partner Management

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

STD UPDATE Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018

Perinatal Hepatitis B Prevention Program. Purpose

EHIVQUAL. For use with ehivqual, an electronic web based program for quality of care data collection and review REVIEW PERIOD:

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

National Network of STD/HIV Prevention Training Centers. Promoting CDC Revised HIV Testing Recommendations Chris Hall, MD, MS

STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention

6. Gonococcal antimicrobial susceptibility

Yakima Health District BULLETIN

Clinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

STD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

Nothing to disclose.

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Sexually transmitted infections (in women)

TO DECREASE THE CHANCE OF GETTING

Answers to those burning questions -

SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)

HCV Infection in the United States

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH

Clinical Practice Objectives

Best practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment:

March 3 - March 9, 2019 (MMWR Week 10)

February 10 - February 16, 2019 (MMWR Week 7)

WHAT DO U KNOW ABOUT STIS?

Illinois Department of Public Health Office of Health Protection HIV/AIDS Section

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

February 24 - March 2, 2019 (MMWR Week 9)

Sexually Transmitted Disease Treatment Tables

5/1/2017. Sexually Transmitted Diseases Burning Questions

Williamson County Influenza Surveillance Williamson County and Cities Health District Final Report August 25, 2015

Management of Syphilis in Patients with HIV

Learning Objectives. STI Update. Case 1 6/1/2016

Opportunities and Challenges for HIV and STD Data Sharing: Data to Care Realities PLENARY 4 11/28/2017

November 4 - November 10, 2018 (MMWR Week 45)

Partner Counseling and Referral Services

New York State Immunization Information System (NYSIIS) New York State Department of Health. Digital Government: Government to Business (G to B)

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

December 30, January 5, 2019 (MMWR Week 1)

Combating Cancer in Kentucky

Nevertheless, NSP grantees may retain some or all program income in the NSP program;

GONORRHEA; ACUTE Does Not Include Chronic Gonorrhea

November 11 - November 17, 2018 (MMWR Week 46)

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

Sexually transmitted infections (in women)

Mahoning County Public Health. Epidemiology Response Annex

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

May 13 - May 19, 2018 (MMWR Week 20)

Overview of Health IT in Massachusetts: Data to Inform and Improve Performance

Florida s HIV Testing Efforts

March 4 - March 10, 2018 (MMWR Week 10)

January 14 - January 20, 2018 (MMWR Week 3)

March 10 - March 16, 2019 (MMWR Week 11)

North Dakota Board of Pharmacy

Trends in STDs among Young People in New York State

April 2 - April 8, 2018 (MMWR Week 14)

Podcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43

September 14, All Medical Providers and Health Care Facilities. NYSDOH Bureau of Immunization

Matching enhances IIS data assessing Tdap and influenza vaccine uptake during pregnancy in Washington State

The National STD Curriculum Official Launch Webinar

Dual Therapy: Symptoms and Screening:

January 21 - January 27, 2018 (MMWR Week 4)

Appendix A: Disease-Specific Chapters

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae

December 10 - December 16, 2017 (MMWR Week 50)

Communicable Diseases

9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before

February 19 - February 25, 2017 (MMWR Week 8)

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL

Blood Pressure Management: A Journey in Quality Improvement Phil E. Yphantides, M.D.

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),

Lessons from MSM PrEP pilots / demonstration projects. Kevin Rebe

Lyme Disease Surveillance in Wisconsin Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/2014

Williamson County Influenza Surveillance

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

S403- Update on STIs for the Generalists

EPI-LOG. West Virginia. Statewide Disease Facts & Comparisons. New surveillance techniques show HIV infection rates went underestimated, says CDC

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

Tobacco Use. Overview. General Data Note. Summary NYSDOH

Williamson County Influenza Surveillance

Williamson County Influenza Surveillance

EPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region. Namitha Reddy Regional Coordinator North/Central West Region

RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Review of Influenza Activity in San Diego County

Dermatologist Venereologist MD, PhD

2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE

Yolo County Chlamydia and Gonorrhea Trends,

Transcription:

The Local Health Performance Incentive Program: Year 3 Office of Public Health Practice

Background & General Program Overview Christopher Davis, PhD Office of Public Health Practice

3 Background In 2012 NYS amended Article 6 of Public Health Law Included the creation of the statewide performance based incentive program Allows DOH to set performance standards for core public health services $1 million appropriated for incentive awards

4 Year 1 Performance Incentive Year 1 focused on General Communicable Disease Timeliness of reports Completeness of reports Goal was to impact public health by ensuring public health investigations were complete and conducted ASAP Designed to only award a handful of top performing counties Every county greatly surpassed expectations Decided to award all counties, with amount of awards varying by population size. Lowest scoring county was 98%.

5 Year 2 In Year 2, DOH chose to focus on Sexually Transmitted Disease (STD) measures Adequate Treatment of Gonorrhea Completeness of Electronic Syphilis Serology Registry Continuation of Year 1 Communicable Disease Measures» Sustain performance results achieved in 2013-2014 Designed to award a handful of counties Results greatly exceeded expectations once again Awarded 93% of counties

Each year DOH program focus area provided local training and Technical assistance For Year 1 and 2 LHD Training & Technical Assistance Live webinar w/archive One-to-One Training & T.A. provided by BSTDPE Monthly summary tables posted to Health Commerce System LHD-specific line-listed CDESS data Resources: FAQ document, e-syphilis Serology Manual, STD clinical consultation Plan to offer similar assistance for year 3. 6

7 Year 3 Two Parts Environmental Health (EH) In conjunction with 2015 ipad/tablet distribution, move LHDs toward electronic inspection submittals to improve the timeliness, completeness, and data quality of inspection submittals. STD Maintain efforts to ensure that syphilis serology reports are complete and that gonorrhea is treated as per CDC guidelines.

8 Participation Full-service LHDs that deliver EH services must participate in both parts of the incentive program to be eligible to receive award. LHDs that do not deliver EH services can compete for portion of awards to support performance on STD measures.

9 Measurement Three key measures Proportion of EH inspections submitted electronically Proportion of adequately treated gonorrhea cases Proportion of syphilis investigations with a complete E-Syphilis serology record

10 Scoring NYSDOH will use proportion of EH inspections submitted electronically and reports that meet or exceed minimum goals in each STD performance area and enter data into weighted formula, as follows: County Goal Achievement Score=[54*(proportion of EH eforms submittals)+12*(proportion of gonorrhea cases receiving adequate treatment)+6*(proportion of syphilis serology record meeting completeness goal//72*100%

11 Award Eligibility Counties Providing EH Services Each LHD will get base award according to when they started using electronic inspection technology. Each LHD that then meets minimum performance goals will be eligible for additional award, based on burden of active operations. Counties without EH Services LHD meeting minimum performance goals will be eligible for additional award, based on population size.

12 Performance Awards for EH LHDs Annual Active Operations Number of LHDs in Size Group Number of Awards Available Amount ($) of Each Award Total $ Amount <1020 16 8 22,000 176,000 1021<3000 10 5 40,000 200,000 >3000 10 5 50,000 250,000

13 Performance Awards for LHDs without EH Population Group Number of LHDs in Size Group Number of Awards Available Amount ($) of Each Award Total $ Amount <75,000 7 5 15,000 75,000 75,000+ 14 10 17,500 175,000

14 Year 3 Timeline Activity Nov 2015 Dec Jan 2016 Feb Mar Apr May June July Aug Sep Launch Initiative X Performance Period X X X X X X X Data analyzed and award formula applied Results announced at NYSACHO meeting X X X X

15 Environmental Health Claudine Jones Rafferty Division of Environmental Health Protection

16 Environmental Health Incentive Focus Submittal of electronic inspection reports (eforms) for EH regulatory inspection and protection programs Goal Maximize the proportion of eforms submitted to ehips Counties must exceed baseline to be eligible for performance award

17 Environmental Health Awards 3 Levels of Base Financial Awards: Early Adopters Phase 1 Implementation (2013) Emerging Users Phase 2 Implementation (2014) New Users All Other LHDs

18 Environmental Health Awards Early Adopters Phase 1 Implementation (2013) Voluntary Participation LHDs Provided Own Equipment Nine (9) LHDs Initially Indicated Interest

19 Environmental Health Awards Emerging Users Phase 2 Implementation (2014) Voluntary Participation LHDs Provided Own Equipment Broader LHD Participation & Use of eforms

20 Environmental Health Awards New Users DOH Survey of Interested LHDs DOH Encouraged Participation DOH Purchase of Equipment for LHDs All LHDs Indicate Interest in eforms Implementation

21 EH Base Financial Awards LHD User Category Participation Level Base Award Amount 2013 - Phase 1 Early Adopter 2014 - Phase 2 Emerging User 2015 - Statewide New User eforms Used for 1/3 of Environmental Inspections Prior to 2014 eforms Use Initiated But in Lesser Quantities Prior to 2015 eforms Participation Indicated DOH (or LHD) Equipment $10,000.00 $3,250.00 $1,500.00

22 Environmental Health Incentive Overall Objectives Encourage and Incentivize LHDs to Use eforms for Inspection Submittals Improve Inspection Data Quality in ehips for Enhanced Regulatory Oversight Minimize LHD Burden of Data Entry and In-Office Time

23 Sexually Transmitted Disease Alison Muse Bureau of STD Prevention and Epidemiology

24 Sexually Transmitted Diseases Continue Year 2 Performance Measures Adequate Treatment of N. gonorrhoeae infections Completeness of Electronic Syphilis Serology Registry

Adequate Treatment of Gonorrhea 25 Presidential EO 13676: National Strategy to Combat Antibiotic Resistant Bacteria Delay emergence of cephalosporin-resistant N. gonorrhoeae Promote adherence to recommended treatment

CDC Updated Treatment Guidelines - 2015 Uncomplicated Gonococcal Infections of Cervix, Urethra & Rectum Recommended Dual Therapy 26 Ceftriaxone 250 mg in a single IM dose PLUS Azithromycin 1 g orally in a single dose Administered together on the same day MMWR 2015;64 (No. RR-3):60-68 26

27 CDC Updated Treatment Guidelines - 2015 Uncomplicated Gonococcal Infections of Cervix, Urethra & Rectum Alternative # 1: Ceftriaxone unavailable Cefixime 400 mg in a single oral dose PLUS Azithromycin 1 g orally in a single dose Administered together on the same day MMWR 2015;64 (No. RR-3):60-68 27

CDC Updated Treatment Guidelines - 2015 Uncomplicated Gonococcal Infections of Cervix, Urethra & Rectum Alternative # 2: Cephalosporin-allergy Gemifloxacin 320 mg orally in a single dose PLUS Azithromycin 2 g orally in a single dose OR Gentamicin 240 mg IM single dose PLUS Azithromycin 2 g orally in a single dose 28 MMWR 2015;64 (No. RR 3):60-68 28

Adequate Treatment of N. gonorrhoeae Denominator: All reported cases of gonorrhea Numerator: # reported cases meeting criteria for adequate treatment as follows: Treatment type & dosage for each of two antibiotics Antibiotics reflect recommended dual regimen in 2015 CDC STD Treatment Guidelines A valid date of treatment for each antibiotic Same date of administration for each of 2 drugs * Based on documentation in CDESS supplemental 29

CDESS Supplemental Modifications Provider and patient factors influence treatment and may be beyond LHD control. For example: Drug allergy Patient lost to follow up Non-NYS Provider i.e., no treatment information available CDESS supplemental has been amended to permit LHDs to document these extenuating circumstances Records excluded from performance measurement calculation

Completeness of E-Syphilis Serology Registry CDESS Module established in 2008 Centralized repository Patient-specific history of syphilis testing & treatment, regardless of case definition status Allows LHDs to view and transfer records across jurisdictions Promotes security of patient information Increases timeliness of investigation 31

Completeness of E-Syphilis Serology Registry Denominator: Numerator: All ECLRS lab results for syphilis, includes cases and non-cases # ECLRS lab results transferred to a syphilis serology record AND complete data for the following fields:» Specimen collection date» Laboratory analysis date» Test type and results for non-treponemal and treponemal tests» Specimen source» Accession number/reporting laboratory * Based on documentation in CDESS supplemental 32

33 Goals for STD Ensure that 85% of gonorrhea cases will be adequately treated according to CDC guidelines Ensure that 90% of syphilis investigations will have a complete serology record Counties must meet or exceed both of these goals to be eligible for a performance award

STD Performance Indicator Adequate Treatment of Gonorrhea 1 Completeness of e- Syphilis Serology Registry Year 3 Performance Indicator Goal 85% 90% Year 2 PI Baseline 79% 99% # LHDs >= Baseline 18 55 1 Same day treatment with Ceftriaxone and Azithromycin 34

Resources CDESS CDESS Help LHD Performance Page Performance incentive proposal, FAQs, Reports Archived Webinar on Syphilis Serology Registry https://meetny.webex.com/meetny/ldr.php?rcid=41c95 3ec647d146de87ece6cb7789cdc Submit Questions/TA Requests to: stdc@health.ny.gov 35

FAQ and Question & Answer Session

ehips Data Submittals Question 1. What constitutes a manual entry? 2. If an eform is used to submit an initial inspection report, and the LHD modifies or updates the inspection entry, manually, in ehips, does that change the submittal to be recorded as a manual entry? Response 1. Manual Entry means the service was keyed in by person (i.e., manually). 2. No. Any service initially submitted via either an eform or Scannable Form cannot be classified as a manual entry, even if the record is subsequently updated manually.

ehips Data Submittals Question 3. Are entries for complaint investigations, which are performed manually in ehips, being counted as manual entries? Response 3. No. The only service types being included in the counts for the Year 3 Incentive include: inspection, reinspection and pre-operational inspection. Field visit, HACCP, sanitary survey complaint, incident or illness investigation are not included or counted as service types.

ehips Data Submittals Question 4. Water program staff may occasionally enter field services at a regulated facility, if it relates to the water supply operation; will those services be counted as a manual entry for this incentive program? Response 4. It may depend on the service types being entered by your water program staff. The counted service types (i.e., inspection, reinspection and preoperational inspection) are not routinely used by the water program.

ehips Data Submittals Question 5. When will the eform be available for the Healthy Neighborhood Program (HNP)? 6. What happens if the eform for HNP is not made available during the incentive period? Response 5. An eform for the HNP is being developed and is targeted to be available in January 2016. 6. In this case, no HNP eform submittals will be counted under the incentive.

ehips Data Submittals Question 8. How will the HNP eform submittals be counted, once the form becomes available? 9. What if I have any further questions about eforms or the Environmental Health portion of the incentive? Response 8. Any eform submittals for HNP services performed during the incentive period will be counted and included in the final count of all eform submittals. 9. Questions relating to eforms or the EH incentive should be submitted to: ehips@health.ny.gov

Additional Questions? 42